Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial JFR Robertson, IM Bondarenko, E Trishkina, M Dvorkin, L Panasci, ... The Lancet 388 (10063), 2997-3005, 2016 | 610 | 2016 |
Fulvestrant plus anastrozole or placebo versus exemestane alone after progression on non-steroidal aromatase inhibitors in postmenopausal patients with hormone-receptor … SRD Johnston, LS Kilburn, P Ellis, D Dodwell, D Cameron, L Hayward, ... The Lancet Oncology 14 (10), 989-998, 2013 | 332 | 2013 |
Concepts of seroma formation and prevention in breast cancer surgery A Agrawal, AA Ayantunde, KL Cheung ANZ Journal of surgery 76 (12), 1088-1095, 2006 | 296 | 2006 |
Tumour marker measurements in the diagnosis and monitoring of breast cancer KL Cheung, CRL Graves, JFR Robertson Cancer treatment reviews 26 (2), 91-102, 2000 | 263 | 2000 |
Prognostic factors for patients with hepatic metastases from breast cancer L Wyld, E Gutteridge, SE Pinder, JJ James, SY Chan, KL Cheung, ... British journal of cancer 89 (2), 284-290, 2003 | 227 | 2003 |
Brain metastases from breast cancer: identification of a high-risk group AJ Evans, JJ James, EJ Cornford, SY Chan, HC Burrell, SE Pinder, ... Clinical Oncology 16 (5), 345-349, 2004 | 212 | 2004 |
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer DP Forward, KL Cheung, L Jackson, JFR Robertson British journal of cancer 90 (3), 590-594, 2004 | 185 | 2004 |
Bone metastases from breast carcinoma: histopathological–radiological correlations and prognostic features JJ James, AJ Evans, SE Pinder, E Gutteridge, KL Cheung, S Chan, ... British journal of cancer 89 (4), 660-665, 2003 | 177 | 2003 |
Updated recommendations regarding the management of older patients with breast cancer: a joint paper from the European Society of Breast Cancer Specialists (EUSOMA) and the … L Biganzoli, NML Battisti, H Wildiers, A McCartney, G Colloca, IH Kunkler, ... The Lancet Oncology 22 (7), e327-e340, 2021 | 164 | 2021 |
The assessment and management of older cancer patients: a SIOG surgical task force survey on surgeons' attitudes F Ghignone, BL Van Leeuwen, I Montroni, MG Huisman, P Somasundar, ... European Journal of Surgical Oncology (EJSO) 42 (2), 297-302, 2016 | 134 | 2016 |
Neoadjuvant chemotherapy for locally advanced breast cancer: a review of the literature and future directions J Mathew, KS Asgeirsson, KL Cheung, S Chan, A Dahda, JFR Robertson European Journal of Surgical Oncology (EJSO) 35 (2), 113-122, 2009 | 126 | 2009 |
Gefitinib (ZD1839) is active in acquired tamoxifen (TAM)-resistant oestrogen receptor (ER)-positive and ER-negative breast cancer: results from a phase II study R JFR Proc Am Soc Clin Oncol, 2003 | 117 | 2003 |
Fulvestrant-a novel endocrine therapy for breast cancer SJ Johnston, KL Cheung Current medicinal chemistry 17 (10), 902-914, 2010 | 109 | 2010 |
Biology of primary breast cancer in older women treated by surgery: with correlation with long-term clinical outcome and comparison with their younger counterparts BM Syed, AR Green, EC Paish, D Soria, J Garibaldi, L Morgan, ... British journal of cancer 108 (5), 1042-1051, 2013 | 100 | 2013 |
The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast Z Hodi, J Chakrabarti, AHS Lee, JE Ronan, CW Elston, KL Cheung, ... Journal of clinical pathology 60 (3), 299-302, 2007 | 98 | 2007 |
Priorities for the global advancement of care for older adults with cancer: an update of the International Society of Geriatric Oncology Priorities Initiative M Extermann, E Brain, B Canin, MN Cherian, KL Cheung, N de Glas, ... The Lancet Oncology 22 (1), e29-e36, 2021 | 95 | 2021 |
Cyclin E overexpression sensitizes triple-negative breast cancer to Wee1 kinase inhibition X Chen, KH Low, A Alexander, Y Jiang, C Karakas, KR Hess, JPW Carey, ... Clinical Cancer Research 24 (24), 6594-6610, 2018 | 94 | 2018 |
Serum epidermal growth factor receptor and HER2 expression in primary and metastatic breast cancer patients KS Asgeirsson, A Agrawal, C Allen, A Hitch, IO Ellis, C Chapman, ... Breast Cancer Research 9, 1-8, 2007 | 90 | 2007 |
Endoscopic stenting for malignant biliary obstruction KL Cheung, ECS Lai Archives of Surgery 130 (2), 204-207, 1995 | 85 | 1995 |
Endocrine therapy for breast cancer: an overview KL Cheung The Breast 16 (4), 327-343, 2007 | 84 | 2007 |